Immunocompromised women are at increased risk of having HPV detected and developing HPV-related diseases such as genital warts, anogenital dysplasia, and cancer. This review aims to summarize the current literature regarding the immunogenicity of the HPV vaccine in immunocompromised women and to discuss whether HPV vaccination may be able to reduce the risk of cervical dysplasia and cancer. HPV vaccination induces an immune response in these women; however, it is unknown whether vaccination is effective in reducing the risk of cervical dysplasia and cancer. Further research is needed.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
dysplasia cancer
12
immunocompromised women
8
hpv vaccination
8
risk cervical
8
cervical dysplasia
8
[not available]
4
available] immunocompromised
4
women increased
4
increased risk
4
hpv
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!